ImmuCell(ICCC) - 2024 Q3 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 8, 2024 ImmuCell Corporation | --- | --- | |-----------------------------------------------------------------------------------------|-----------------------| | (Exact name of registrant as specified in its charter) \nDE 001-12934 | 01-0382980 | | (State or other jurisdiction (Commission ...